A new US study looking at the safety and effectiveness of new medication developed from adult stem cells for the treatment of ischaemic stroke has opened at University Hospitals (UH) Case Medical Center, Cleveland, USA. The phase 2 study will use a cell therapy product called MultiStem (Athersys).
MicroVention, a wholly owned subsidiary of Terumo, has announced initiation of patient enrolment in its HEAT (Hydrogel endovascular aneurysm treatment) clinical trial.
Endovascular therapy (EVT) is associated with significantly better treatment outcomes over traditional intravenous tPA (IVT) for patients suffering acute ischaemic stroke resulting from blockages in the large vessels of the brain, according to a study presented at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting (San Diego, USA, 23–27 July).
A new study of optical coherence tomography (OCT) confirms the safety and feasibility of this imaging technique in the carotid arteries. However, because of cost issues, OCT still has a long road to travel to become widely utilized, according to a study recently published in the current issue of the Journal of Endovascular Therapy.
A correlation between brain aneurysms, bulges or balloons in vessel walls, and early onset menopause has been identified, according to recent study results presented at the Society of NeuroInterventional Surgery (SNIS) 9th Annual Meeting (San Diego, USA, 23–27 July) thereby suggesting that the premature loss of estrogen could be a risk factor for aneurysm formation and development.
Blockade Medical has received CE mark for its Barricade Coil System which is designed to occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels.
Preliminary data regarding the use of the Web Aneurysm Embolization System (Sequent Medical) were shared at LINNC 2012 in Paris, France, and published in a recent study in the American Journal of Neuroradiology. The early evidence suggests that this device represents a feasible and promising treatment for wide-neck bifurcation aneurysms, and that further study and clinical experience is warranted.
Adding stroke severity to a hospital 30-day mortality model based on claims data for Medicare beneficiaries with acute ischaemic stroke was associated with improvement in predicting the risk of death at 30 days and changes in performance ranking regarding mortality for a considerable proportion of hospitals, according to a study published by Gregg C Fonarow, University of California, Los Angeles, USA, and colleagues.
Lazarus Effect has received CE mark for its Lazarus Funnel Guide Catheter. The device is a single-lumen catheter designed to enhance the introduction and removal of interventional devices, including those used to treat acute ischaemic stroke.
Intravascular optical coherence tomography (OCT) proved safe, feasible, and capable of providing high-quality images in patients undergoing protected carotid artery stenting, results of a small clinical study showed.
The term“intracranial aneurysm” is a purely descriptive term meaning a widening of the lumen of a segment of an intracranial artery. It is also a collective term for a rather large group of different diseases affecting the extra- and/or intradural portions of intracranial arteries in a segmental, focal or multifocal pattern. Since the currently available non-invasive and invasive neuroimaging modalities, i.e. cross-sectional native and contrast-enhanced CT and MRI, CT- and MR-angiography, or DSA, almost exclusively depict the lumen of intracranial aneurysms but not, or insufficiently, their other components (i.e. the wall and the perianeurysmal space), neurointerventionists tend to base their research and collaboration on developing treatment tools, their clinical decisions, therapeutic actions and follow-up evaluations on the easily visualised lumen. Accordingly, the majority of the currently used classification systems and treatment guidelines for such aneurysms are lumen-oriented and therefore incomplete. This misleads one to view intracranial aneurysms as simple, more or less focal expansions or ectasias of the parent artery lumen induced by haemodynamic forces, such as flow, shear stress and turbulence, instead of considering them to be pathomorphological expressions of distinct pathobiological processes leading to degradation, activation, overproduction or proliferation of a distinct, genetically or otherwise vulnerable segment of the wall of an intracranial artery within a specific local perianeurysmal environment.
Blockade Medical™ announced today that it has received CE Mark (Conformité Européenne) for its Barricade Coil System™. The Barricade Coil System is designed to remove or endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. The CE Mark allows the Company to market the Barricade Coil System in the European Union and other countries that recognize the CE Mark for commercial distribution purposes The Barricade Coil System provides the neurovascular specialist with a complete coil embolization line that can occlude complex neurovascular aneurysms and other vascular abnormalities.
Our ability to see inside the arteries of vascular disease patients in stunning high resolution before and during stenting procedures can offer a wealth of valuable information. A new study of optical coherence tomography (OCT) confirms the safety and feasibility of this imaging technique in the carotid arteries. However, because of cost issues, OCT still has a long road to travel to become widely utilized.
According to a new report by iData Research (http://www.idataresearch.net), the leading global authority in medical device market research, the European neurological device market was valued at over €600 million in 2011. The market has shown strong growth over the past few years and is expected to reach nearly €850 million by 2018. Market expansion has been fueled by the continued acceptance of endovascular techniques and neuromodulation devices, increases in the aging population, as well as technological advancements.
Penumbra, Inc., announces the launch of an educational website QuEST2StopStroke.com, designed to empower the public with the knowledge they need to help stop stroke. The website asks visitors to “Join the Quest” and learn where to find their closest advanced stroke center that offers lifesaving inside-the-artery clot removal. The website also provides educational information about ischemic stroke and common treatment methods, as well as testimonials from patients whose lives were saved by the Penumbra System®, an innovative clot-removal technology that uses suction and acts as a tiny “vacuum cleaner” to remove blood clots from the brain.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos